EKTERLY
LIVE

Serial Number

79429992

Owner

Kalvista Pharmaceuticals Limited

Attorney

Stacy L. Wu

Filing Date

Jun 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EKTERLY Trademark

Serial Number: 79429992 • Registration: 8268590

EKTERLY is a trademark filed by Kalvista Pharmaceuticals Limited on June 18, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Kalvista Pharmaceuticals Limited (11 trademarks)

Porton Science Park, Bybrook Road,

Entity Type: 99

Trademark Details

Filing Date

June 18, 2025

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Goods & Services

Pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; pharmaceutical preparations containing sebetralstat for the treatment of angioedema, hereditary angioedema, bradykinin mediated inflammatory disorders, plasma kallikrein or factor XIIa mediated diseases or disorders, or diseases and disorders mediated by the contact activation system

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Apr 2, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
REFUSAL PROCESSED BY IB
Mar 19, 2026 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 18, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 18, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2026 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 28, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 28, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 31, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 30, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 29, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2026 NWOS
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 9, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 9, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 9, 2025 COAR
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 12, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 14, 2025 REPR